source
- Iambic Therapeutics raises $150 million in IPO to fund oncology drug developmentIambic Therapeutics, a San Diego-based AI biotech, completed an initial public offering that raised $150 million, exactly meeting its goal of selling 9.4 million shares at $16 each. The company sa…
- DOJ ramps up health-care fraud investigations, urges companies to self-report and reward remediationAt the STAT Summit in Boston, DOJ officials announced a renewed focus on health-care fraud, especially targeting Medicare and Medicaid schemes. Deputy Assistant Attorney General Jacob Foster said…